Helicobacter Pylori Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions
Conditions: Gastric Xanthoma; Helicobacter Pylori Infection; Gastric Cancer; Intestinal Metaplasia; Precancerous Lesions Sponsors: Xijing Hospital of Digestive Diseases Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

H. Pylori Screen-and-treat Study in a Population of Young Adults
Conditions: Gastric Cancer; H Pylori Infection; H Pylori Eradication; H-pylori Interventions: Drug: Bismuth-based quadruple therapy; Drug: Levofloxacin-based quadruple therapy; Drug: Standard triple therapy; Drug: Levofloxacin-based triple Sponsors: University of Latvia; Clinical Hospital Center Rijeka; Clinical Hospital Centre Zagreb; Beacon Hospital; Wroclaw Medical University; Iuliu Hatieganu University of Medicine and Pharmacy; National Institute of Public Health, Slovenia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
Conditions: Helicobacter Pylori Infection; Peptic Ulcer Hemorrhage Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy: A Retrospective Cohort Study
Conditions: Gastritis H Pylori; Gastritis Chronic; Intestinal Metaplasia Interventions: Procedure: Esophagogastroduodenoscopy; Procedure: Endoscopic biopsy sampling Sponsors: Sisli Hamidiye Etfal Training and Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy
Conditions: Gastritis H Pylori; Gastritis Chronic; Intestinal Metaplasia Interventions: Procedure: Esophagogastroduodenoscopy; Procedure: Endoscopic biopsy sampling Sponsors: Sisli Hamidiye Etfal Training and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection Interventions: Drug: esomeprazole + amoxicillin; Drug: esomeprazole + amoxicillin + clarithromycin + colloidal bismuth tartrate agent; Drug: Vonoprazan + amoxicillin; Drug: Vonoprazan + amoxicillin + clarithromycin Sponsors: The Third Xiangya Hospital of Central South University; Hunan Key Laboratory of Non-resolving Inflammation and Cancer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials

Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma
Conditions: MALT Lymphoma of Stomach; Helicobacter Pylori Infection Interventions: Drug: Triple therapy for eradication of Helicobacter Pylori and Orelabrutinib; Drug: Triple therapy for eradication of Helicobacter Pylori Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection
Conditions: Helicobacter Pylori Infection Interventions: Drug: Bismuth Subcitrate; Drug: Esomeprazole; Drug: Metronidazole; Drug: Amoxicillin; Drug: Clarithromycin; Drug: Levofloxacin Sponsors: National Institute of Public Health, Slovenia; Community Healthcare Center dr. Adolf Drolc Maribor (HCM) Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
DiscussionFor the first time in the Syrian population, this randomized controlled trial will provide objective and accurate evidence about the efficacy of a sequential levofloxacin-based treatment regimen.Trial registrationClinicalTrials.govNCT06065267. Registered on October 3, 2023. Prospective registered. Enrollment of the first participant has not started yet. (Source: Trials)
Source: Trials - January 15, 2024 Category: Research Source Type: clinical trials

Tailored vs. Empirical Helicobacter Pylori Infection Treatment
Conditions: Helicobacter Pylori Infection Interventions: Diagnostic Test: Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test; Drug: Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera ®); Drug: PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days; Drug: PPI, amoxicillin 1g and levofloxacin 250 mg, twice daily, for 10 days; Drug: Bismuth quadruple therapy (Pylera®) for 10 days Sponsors: Manuel Coelho da Rocha Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials

A Phase 1, Multiple Oral Administrations of TNP-2092 Capsules in Asymptomatic Healthy People With Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection Interventions: Drug: TNP-2092 capsules; Drug: Placebo Sponsors: TenNor Therapeutics Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials

Relation of Helicobacter Pylori Infection in Patients With Impaired Glucose Tolerance and Their Lipid Profile in Upper Egypt
Conditions: H.Pylori in Predibetic Patients Interventions: Diagnostic Test: HbA1c Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials

Relation of Helicobacter Pylori in Prediabetic Patients
Conditions: H.Pylori Infection Interventions: Diagnostic Test: HbA1c Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials

Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication
Conditions: the Eradication Rates of Helicobacter Pylori Interventions: Drug: Rabeprazloe+bismuth+amoxicillin+clarithromycin; Drug: Vonoprazan+amoxicillin+clarithromycin 14 days; Drug: Vonoprazan+amoxicillin+clarithromycin 7 days; Drug: Vonoprazan+tetracycline+furazolidone 14 days; Drug: Vonoprazan+tetracycline+furazolidone 7 days; Drug: Vonoprazan+amoxicillin+furazolidone 7 days; Drug: Vonoprazan+amoxicillin+tetracycline 14 days; Drug: Vonoprazan+amoxicillin 7 days; Drug: Vonoprazan+amoxicillin 14 days Sponsors: Xijing Hospital of Digestive Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Conditions: Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer Interventions: Drug: Vonoprazan; Drug: amoxicillin; Drug: Bismuth; Drug: Esomeprazole; Drug: Tetracycline; Drug: Furazolidone Sponsors: Yongquan Shi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials